Benjamin Tseng is a Vice President at DCM, a leading venture capital fund managing over $2 billion in assets based in the Silicon Valley, Beijing, and Tokyo, where he is responsible for sourcing and analyzing new investment opportunities as well as assisting on financing, M&A, and strategic matters for DCM’s diverse set of portfolio companies. His focus areas lie in disruptive opportunities that exist at the intersection of business and science & technology and include connected devices, “Big Data”, next generation “omics” technology, and new models for healthcare. He works actively with a number of companies, including Whistle, FreedomPop, Arrayent, Cognitive Networks, Augmedix, Stride Health, 1Mainstream, and Rayvio.
Prior to DCM, Benjamin was a Senior Associate Consultant with management consulting firm Bain & Company based in the Bay Area where he worked with a number of Fortune 500 technology companies evaluating new markets, strategies, and acquisitions.
Benjamin graduated Phi Beta Kappa with highest honors in Biochemical Sciences and a minor in Mathematical Sciences from Harvard University where his studies focused on understanding complex biological systems using a combination of mathematical and experimental approaches.